Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Regeneron Pharmaceuticals (NQ:REGN)

584.99 +13.63 (+2.39%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,302,127
Open 576.13
Bid (Size) 575.00 (1)
Ask (Size) 599.00 (1)
Prev. Close 571.36
Today's Range 564.91 - 585.26
52wk Range 520.50 - 1,211.20
Shares Outstanding 91,779,465
Dividend Yield 0.15%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Regeneron Prevails over Amgen in Antitrust PCSK9 Lawsuit Protecting Biotech Innovation and Patient Access to Life-Saving Treatments
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
Sanofi To Navigate Tariff Impact With $20 Billion In Spending Through 2030
Sanofi plans $20 billion US investment by 2030 to expand R&D and manufacturing, aiming to boost medicine production and job creation across states. 
Via Benzinga

Performance

YTD
-18.2%
-18.2%
1 Month
+4.9%
+4.9%
3 Month
-13.2%
-13.2%
6 Month
-25.2%
-25.2%
1 Year
-40.2%
-40.2%

More News

Read More
Beyond The Numbers: 16 Analysts Discuss Regeneron Pharmaceuticals Stock
Via Benzinga
Only Half Of S&P 500 Stocks Joined The Tariff-Relief Rally: Time To Buy The Laggards?
Via Benzinga
Topics Stocks
Exposures US Equities
This PVH Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Via Benzinga
Best Biotech Stocks to Buy in 2025
Via MarketBeat
Topics ETFs Economy Government
Exposures COVID-19 Interest Rates Political
REGN Q1 Earnings Call: Pipeline Progress and EYLEA Headwinds Dominate Discussion
Via StockStory
Cathie Wood Says AI Innovation In Healthcare Will Be More 'Profound' Than Autonomous Taxi Networks, Humanoid Robots
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Trump's New Drug Pricing Executive Order Could Rattle Pharma Stocks, With Price Cuts Of Up To 80%: Novo Nordisk, Pfizer And J&J Fall In Premarket
Via Benzinga
Topics Government
Exposures Political
3 of Wall Street’s Favorite Stocks Skating on Thin Ice
Via StockStory
Eli Lilly, Affirm And Regeneron Are Among Top 12 Large-Cap Losers Last Week (May 5-May 9): Are The Others In Your Portfolio?
Via Benzinga
1 Cash-Heavy Stock on Our Buy List and 2 to Ignore
Via StockStory
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.
Via Chartmill
Discover which S&P500 stocks are making waves on Thursday.
Via Chartmill
Thursday's session: gap up and gap down stock in the S&P500 index
Via Chartmill
These S&P500 stocks that are showing activity before the opening bell on Thursday.
Via Chartmill
Price Over Earnings Overview: Regeneron Pharmaceuticals
Via Benzinga
FDA Expands Surprise Inspections At Foreign Drug And Food Facilities, Targets Double Standards In Overseas Manufacturing Oversight
Via Benzinga
Exposures Product Safety
What's going on in today's session: S&P500 movers
Via Chartmill
Uncover the latest developments among S&P500 stocks in today's session.
Via Chartmill
If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today
Via Benzinga
Why Is Israel-Based Generic Drug Focused Teva Pharmaceutical Stock Trading Higher On Monday?
Via Benzinga
Exposures Product Safety
4 Dividend Stocks to Buy on the Pullback
Via The Motley Fool
Regeneron to Highlight Advances at ASCO with Phase 3 Adjuvant Libtayo® (cemiplimab) CSCC Updates and Promising Early Blood Cancer Data with Linvoseltamab Combination
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
Dupixent® (dupilumab) Data Presented at ATS Reinforce Impact of Targeting Key Type 2 Inflammation Drivers to Improve Outcomes for Chronic Respiratory Diseases
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Regeneron Pharmaceuticals publicly traded?
Yes, Regeneron Pharmaceuticals is publicly traded.
What exchange does Regeneron Pharmaceuticals trade on?
Regeneron Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Regeneron Pharmaceuticals?
The ticker symbol for Regeneron Pharmaceuticals is REGN on the Nasdaq Stock Market
What is the current price of Regeneron Pharmaceuticals?
The current price of Regeneron Pharmaceuticals is 584.99
When was Regeneron Pharmaceuticals last traded?
The last trade of Regeneron Pharmaceuticals was at 05/15/25 04:00 PM ET
What is the market capitalization of Regeneron Pharmaceuticals?
The market capitalization of Regeneron Pharmaceuticals is 53.69B
How many shares of Regeneron Pharmaceuticals are outstanding?
Regeneron Pharmaceuticals has 54B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.